Table 1 Clinicopathological characteristics in patients undergoing potentially curative resection for colorectal cancer

From: The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer

 

Patients ( n =147)

Age group (years) (<65/65–74/⩾75)

46/44/57

Sex (male/female)

78/69

Site (colon/rectum)

105/42

Dukes' stage (B/C)

91/56

C-reactive protein (⩽10/>10 mg l−1)

94/53

Tumour characteristics

 Diameter (mm)

40 (10–130)

 Ulceration (no/yes)

72/75

 Differentiation (well/moderate/poor)

18/116/13

 Lymphatic invasion (negative/positive)

124/22

 Venous invasion (negative/positive)

118/28

% Tumour volume

 CD4+ T-lymphocytes

0.90 (0.03–3.57)

 CD8+ T-lymphocytes

1.13 (0.23–6.30)

 CD4+ plus CD8+ T-lymphocytes

2.17 (0.50–8.27)

Adjuvant therapy (no/yes)

116/31

Alive/dead

92/55

 Cancer-specific/intercurrent disease

39/16